These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8529053)

  • 21. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
    Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
    Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons.
    Cepeda C; Colwell CS; Itri JN; Gruen E; Levine MS
    Eur J Neurosci; 1998 Nov; 10(11):3491-7. PubMed ID: 9824462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
    Evans AM; Green KL
    Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dopaminergic agents on antinociception in formalin test.
    Zarrindast MR; Nassiri-Rad S; Pazouki M
    Gen Pharmacol; 1999 Apr; 32(4):517-22. PubMed ID: 10323495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
    Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors play distinct roles in sexual behavior expression of rats with a different sexual motivational tone.
    Guadarrama-Bazante IL; Canseco-Alba A; Rodríguez-Manzo G
    Behav Pharmacol; 2014 Oct; 25(7):684-94. PubMed ID: 25171081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of dopamine D
    Liu XY; Zheng LF; Fan YY; Shen QY; Qi Y; Li GW; Sun Q; Zhang Y; Feng XY; Zhu JX
    Am J Physiol Cell Physiol; 2022 Mar; 322(3):C327-C337. PubMed ID: 34986020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
    Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
    PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S; Cabib S
    Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats.
    Horiguchi M; Hannaway KE; Adelekun AE; Huang M; Jayathilake K; Meltzer HY
    Behav Brain Res; 2013 Feb; 238():36-43. PubMed ID: 23018127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions.
    Fornaguera J; Huston JP; Carey RJ; Schwarting RK
    Psychopharmacology (Berl); 1995 May; 119(2):145-54. PubMed ID: 7659761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions.
    Asin KE; Montana WE
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1033-41. PubMed ID: 2572001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.
    Borowsky B; Kuhn CM
    Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature.
    Yatsu T; Uchida W; Inagaki O; Tanaka A; Takenaka T
    Gen Pharmacol; 1997 Aug; 29(2):229-32. PubMed ID: 9251904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.